Related references
Note: Only part of the references are listed.Cannabis use and non-clinical dimensions of psychosis in university students presenting to primary care
R. Skinner et al.
ACTA PSYCHIATRICA SCANDINAVICA (2011)
Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users
Eugene W. Schwilke et al.
ADDICTION (2011)
Role of Cannabinoids in the Development of Fatty Liver (Steatosis)
Vishnudutt Purohit et al.
AAPS JOURNAL (2010)
Delta(9)-Tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol
Frances R. Levin et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
Do Δ9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?
Erin L. Karschner et al.
ADDICTION (2009)
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Roger G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Evaluation of the DNA Damaging Potential of Cannabis Cigarette Smoke by the Determination of Acetaldehyde Derived N-2-Ethyl-2 '-deoxyguanosine Adducts
Rajinder Singh et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Pharmacotherapy for Cannabis Dependence How Close Are We?
Ryan Vandrey et al.
CNS DRUGS (2009)
Extended urinary Δ9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure
Ross H. Lowe et al.
DRUG AND ALCOHOL DEPENDENCE (2009)
Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation
Guy A. Cabral et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Identifying New Cannabis Use with Urine Creatinine-Normalized THCCOOH Concentrations and Time Intervals Between Specimen Collections
Michael L. Smith et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2009)
Implications of Plasma Δ9-Tetrahydrocannabinol, 11-Hydroxy-THC, and 11-nor-9-Carboxy-THC Concentrations in Chronic Cannabis Smokers
Erin L. Karschner et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2009)
Studies on the metabolism of the Δ9-tetrahydrocannabinol precursor Δ9-tetrahydrocannabinolic acid A (Δ9-THCA-A) in rat using LC-MS/MS, LC-QTOF MS and GC-MS techniques
Julia Jung et al.
JOURNAL OF MASS SPECTROMETRY (2009)
Adverse health effects of non-medical cannabis use
Wayne Hall et al.
LANCET (2009)
Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy
Robert E. Blair et al.
NEUROPHARMACOLOGY (2009)
Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC)
Claudine C. Hunault et al.
PSYCHOPHARMACOLOGY (2009)
Alterations to pre-pulse inhibition (PPI) in chronic cannabis users are secondary to sustained attention deficits
Kirsty Elizabeth Scholes et al.
PSYCHOPHARMACOLOGY (2009)
Driving under the influence of cannabis: Links with dangerous driving, psychological predictors, and accident involvement
Isabelle Richer et al.
ACCIDENT ANALYSIS AND PREVENTION (2009)
The endocannabinoid system: emotion, learning and addiction
Fabricio A. Moreira et al.
ADDICTION BIOLOGY (2008)
Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence
Jack R. Cornelius et al.
ADDICTIVE BEHAVIORS (2008)
A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions
David Moir et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Executive function deficits in short-term abstinent cannabis users
Sue McHale et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Urinary Elimination of 11-Nor-9-Carboxy-Δ9-tetrahydrocannnabinol in Cannabis Users During Continuously Monitored Abstinence
Robert S. Goodwin et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2008)
Cannabis withdrawal in the United States: Results from NESARC
Deborah S. Hasin et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Neurobiological mechanisms of cannabinoid addiction
L. Fattore et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC
Claudine C. Hunault et al.
PSYCHOPHARMACOLOGY (2008)
Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress
Marco Bortolato et al.
BIOLOGICAL PSYCHIATRY (2007)
Endocannabinoid system involvement in brain reward processes related to drug abuse
Marcello Solinas et al.
PHARMACOLOGICAL RESEARCH (2007)
Cannabinoids elicit antidepressant-like Behavior and activate Serotonergic neurons through the medial prefrontal cortex
Francis Rodriguez Bambico et al.
JOURNAL OF NEUROSCIENCE (2007)
The differential relationship between cocaine use and marijuana use on decision-making performance over repeat testing with the Iowa Gambling Task
Antonio Verdejo-Garcia et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
The endocannabinoid system and extinction learning
Beat Lutz
MOLECULAR NEUROBIOLOGY (2007)
Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality
Pattipati S. Naidu et al.
PSYCHOPHARMACOLOGY (2007)
Detection of Δ9-tetrahydrocannabinolic acid A in human urine and blood serum by LC-MS/MS
Julia Jung et al.
JOURNAL OF MASS SPECTROMETRY (2007)
Marijuana use motives: Concurrent relations to frequency of past 30-day use and anxiety sensitivity among young adult marijuana smokers
Marcel O. Bonn-Miller et al.
ADDICTIVE BEHAVIORS (2007)
The toxicology of cannabis and cannabis prohibition
Franjo Grotenhermen
CHEMISTRY & BIODIVERSITY (2007)
Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test
Fabricio A. Moreira et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Anxiolytic-like properties of the anandamide transport inhibitor AM404
Marco Bortolato et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Δ9-Tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids
Robert S. Goodivin et al.
THERAPEUTIC DRUG MONITORING (2006)
Two brain sites for cannabinoid reward
A Zangen et al.
JOURNAL OF NEUROSCIENCE (2006)
The cannabis withdrawal syndrome
AJ Budney et al.
CURRENT OPINION IN PSYCHIATRY (2006)
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
AW Zuardi et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2006)
Effects of delta-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in marijuana, on human sperm function in vitro
LB Whan et al.
FERTILITY AND STERILITY (2006)
The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers
DA Gorelick et al.
AMERICAN HEART JOURNAL (2006)
Drugs of Abuse, Immune Modulation, and AIDS
Guy A. Cabral
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2006)
Coma due to cannabis toxicity in an infant
Andrew Appelboam et al.
EUROPEAN JOURNAL OF EMERGENCY MEDICINE (2006)
Cannabis withdrawal among non-treatment-seeking adult cannabis users
ML Copersino et al.
AMERICAN JOURNAL ON ADDICTIONS (2006)
An affective-motivational model of marijuana and alcohol problems among college students
JS Simons et al.
PSYCHOLOGY OF ADDICTIVE BEHAVIORS (2005)
Cannabis use to enhance sportive and non-sportive performances among French sport students
FO Lorente et al.
ADDICTIVE BEHAVIORS (2005)
Modern antipsychotic drugs: a critical overview
DM Gardner et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops
FTA Pijlman et al.
ADDICTION BIOLOGY (2005)
Endocannabinoid signaling system and brain reward: Emphasis on dopamine
EL Gardner
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Cannabis withdrawal in adolescent treatment seekers
R Vandrey et al.
DRUG AND ALCOHOL DEPENDENCE (2005)
Relations between cannabis use and dependence, motives for cannabis use and anxious, depressive and borderline symptomatology
H Chabrol et al.
ADDICTIVE BEHAVIORS (2005)
Acute marijuana effects on human risk taking
SD Lane et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Effects of prenatal cigarette and marijuana exposure on drug use among offspring
AJ Porath et al.
NEUROTOXICOLOGY AND TERATOLOGY (2005)
Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear
JP Chhatwal et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?
JL Croxford et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice
J Haller et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Dose related risk of motor vehicle crashes after cannabis use
JG Ramaekers et al.
DRUG AND ALCOHOL DEPENDENCE (2004)
Marijuana and cannabinoid regulation of brain reward circuits
CR Lupica et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients
DT Wade et al.
MULTIPLE SCLEROSIS (2004)
The incidence of drugs in drivers killed in Australian road traffic crashes
OH Drummer et al.
FORENSIC SCIENCE INTERNATIONAL (2003)
Effects of THC on behavioral measures of impulsivity in humans
J McDonald et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Early-onset cannabis use and cognitive deficits: what is the nature of the association?
HG Pope et al.
DRUG AND ALCOHOL DEPENDENCE (2003)
Dose-related neurocognitive effects of marijuana use
KI Bolla et al.
NEUROLOGY (2002)
Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol
F Berrendero et al.
PSYCHOPHARMACOLOGY (2002)
The endogenous cannabinoid system controls extinction of aversive memories
G Marsicano et al.
NATURE (2002)
Comparison of the subjective effects of Δ9-tetrahydrocannabinol and marijuana in humans
SR Wachtel et al.
PSYCHOPHARMACOLOGY (2002)
Neuropsychological performance in long-term cannabis users
HG Pope et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Temporal indication of marijuana use can be estimated from plasma and urine concentrations of Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, and 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid
JE Manno et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2001)
Δ9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol®:: Results of a clinical study
MA ElSohly et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2001)
Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana
RS Niedbala et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2001)
Pharmacology and effects of cannabis: a brief review
CH Ashton
BRITISH JOURNAL OF PSYCHIATRY (2001)
The effects of adolescent cannabis use on educational attainment: a review
M Lynskey et al.
ADDICTION (2000)
Share Paper
